Credit rating agency, India Rating & Research has affirmed India - based Claris Lifesciences’ Long Term issuer rating at ‘A-’ on Rating Watch Positive (RWP). This reflects the significant improvement in the company’s Credit profile and improvement in credit metrics.
Claris Lifesciences has recently received the long awaited USFDA approval for its manufacturing facility. The company now has nine ANDAs approved in its name across four molecules. The company has a total filing of 30 ANDAs across 20 products.
